Amyloid polyneuropathy caused by wild‐type transthyretin

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-4598|52|1|146-149

ISSN： 0148-639x

Source： MUSCLE AND NERVE, Vol.52, Iss.1, 2015-07, pp. : 146-149

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Heart Failure Complicated by Alveolar Hemorrhage due to Vascular Collapse and Amyloid Deposits in Wild-Type Transthyretin Amyloidosis

By  

Cardiology, Vol. 135, Iss. 4, 2016-08 ,pp. : 216-220

Karger

Access to resources Recommend Favorite

THAOS – The Transthyretin Amyloidosis Outcomes Survey: initial report on clinical manifestations in patients with hereditary and wild-type transthyretin amyloidosis

By Coelho Teresa   Maurer Mathew S.   Suhr Ole B.  

Current Medical Research and Opinion, Vol. 29, Iss. 1, 2013-01 ,pp. : 63-76

Informa Healthcare

Access to resources Recommend Favorite

Tafamidis delays neurological progression comparably across Val30Met and non‐Val30Met genotypes in transthyretin familial amyloid polyneuropathy

By  

EUROPEAN JOURNAL OF NEUROLOGY, Vol. 25, Iss. 3, 2018-03 ,pp. : 464-468

John Wiley & Sons Inc

Access to resources Recommend Favorite

Antibody recognition of amyloidogenic transthyretin variants in serum of patients with familial amyloidotic polyneuropathy

By Palha Joana Almeida   Moreira Paulo   Olofsson Anders   Lundgren Erik   Saraiva Maria João  

Journal of Molecular Medicine, Vol. 78, Iss. 12, 2001-02 ,pp. : 703-707

Springer Publishing Company

Access to resources Recommend Favorite

Quality of life in patients with K‐RAS wild‐type colorectal cancer

By  

CANCER, Vol. 120, Iss. 2, 2014-01 ,pp. : 181-189

John Wiley & Sons Inc

Access to resources Recommend Favorite